Click on a filter below to refine your search. Remove a filter to broaden your search.
For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare.
The idea is backed by more than 60 countries, including the United States.
Improvement in neural functioning also was seen during a 12-week intervention.
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
Full approval could help boost vaccination efforts in the United States.
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.
Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point.
Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients
The approval was based on two Phase 3 trials showing that more than 50% of patients receiving Skyrizi achieved an ACR20 response at 24 weeks.
The general pattern showed higher hazard ratios with higher noise exposure, with levelling off or a decline at higher noise levels.